Licensable host strain

Staphylococcus aureus

PB-SA008

A genomically fully characterised, closed-genome clinical isolate, available to license for research and commercial applications.

€3,900per strain, one-time licence
Complete closed genome
Chromosome
2 plasmids1

Genomic properties

2.80 MbGenome size
1Plasmids
1Prophages
0 of 1Complete prophages
ST1289MLST sequence type
NACapsule type
7Anti-phage defense systems
Original isolation: Before 2016, Finland.

Resistance profile

Predicted resistance by drug class.

Beta-lactam, Methicillin, Tetracycline, Trimethoprim

Virulence

Virulence factors by functional category.

Adherence, Immune evasion, Protease, Toxin

Anti-phage defense

Systems detected that shape phage susceptibility.

AbiD, DMS (other), PDC-M24, PDC-S07, RM type IV, RosmerTA, SoFic

Included with your purchase

Annotated genomeComplete GenBank with genes plus resistance, virulence and defense features.
Characterisation reportFull PDF covering assembly, taxonomy and functional annotation.
Assembled sequenceClosed, high-quality assembly (FASTA) of the chromosome and plasmids.
Freeze-dried vialEach bacterial strain is supplied in a freeze-dried vial and packaged in accordance with packing instruction P650 and the general UN3373 IATA requirements to ensure safe transport and maintain stability during shipping.

Licence terms

Every strain in the collection is supplied under the same standard licence. This summary sets out what it allows and where its limits are.

Non-exclusive

Perpetual

Worldwide

Royalty-free after purchase

Purchasing legal entity

Intended use

Our bacterial strains are available to B2B customers for commercial R&D and the development of commercial applications, including human and animal health research, antimicrobial R&D, and laboratory technology development.

Regulatory and biosafety requirements

Purchasers must comply with their country's regulations and obtain all necessary import, possession and use permits before ordering. International shipping is available subject to applicable import and export shipping requirements.

Purchasers and end users are responsible for appropriate biosafety measures, trained personnel, and the safe handling, storage, and disposal of bacterial strains.

The licence permits

✓

Commercial R&D, screening, development of commercial applications, validation, QC and approved CRO work.

✓

Ownership of your independently developed inventions, products, data and results.

The licence does not permit

✕

Resale or redistribution of the original strain as a standalone product.

✕

Supply of the strain to unrelated third parties.

✕

Sublicensing of the strain or genome as a standalone product.

✕

Resale of the genomic data as a competing reference dataset.

✕

Human or animal administration of the strain.

✕

Environmental release or other unauthorised use.

Contact us for exclusive licensing

All purchases include a non-exclusive licence granting the rights specified under our standard licence terms. If you wish to obtain an exclusive licence for a bacterial strain, please contact us directly.

An exclusive licence grants you sole commercial use rights to the licensed strain, which will no longer be available for purchase or licensing to third parties. Pricing for exclusive licences is agreed separately.

Ask us about an exclusive licence

These terms are a summary provided for information. The executed licence agreement supplied with your purchase sets out the binding terms.

Connect

Get in Touch

Thank you! Your submission has been received!
Something went wrong . Please check the fields and try again.

We’re here to help with any questions you may have. You can also find our team members and their contact details on the Team page.

Nitin Agrawal
Nitin Agrawal
Sales Associate
nitin.agrawal@precisionphage.com
Matti Jalasvuori
Matti Jalasvuori
Chief Executive Officer (CEO)
matti.jalasvuori@precisionphage.com
phage dna genome circle